Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia 2020-10-29 09:35
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate 2020-10-29 07:15
BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures 2020-10-29 02:51
Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus 2020-10-28 22:36
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments 2020-10-28 20:00
APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia 2020-10-28 14:00
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history 2020-10-27 20:00
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market 2020-10-27 10:42
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China 2020-10-27 08:13
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) 2020-10-27 07:23
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus 2020-10-26 16:35
RhoVac Participates in BIO Europe Digital 2020-10-26 16:26
Article on RhoVac's Phase I/II study to be published in November 2020-10-26 15:51
/C O R R E C T I O N -- Azura Ophthalmics/ 2020-10-23 07:16
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities 2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting 2020-10-22 19:30
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China 2020-10-22 10:36
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China 2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification 2020-10-21 10:00
One broken bone leads to another, warns IOF on World Osteoporosis Day 2020-10-21 06:18
1 145 146 147 148 149 233